Alpha Cognition Inc. Common Stock (ACOG) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में वित्तीय सेवाएं क्षेत्र, संचालन करती है Financial - Conglomerates उद्योग. कंपनी का मुख्यालय है Vancouver, BC, Canada. वर्तमान CEO हैं Michael E. McFadden.
ACOG के पास है IPO तिथि 2024-11-12, 5 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Market, बाजार पूंजीकरण $102.82M.
Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.
